Brandon Capital
Investor profile
Venture capital
Brandon Capital has backed 3 European tech companies across 4 funding rounds between 2022 and 2025, joining rounds totalling €197M. Most active in Healthtech. Data as of Nov 2026.
Deals
4
distinct rounds
Companies
3
backed
Active span
2022–2025
4 yrs
Total round €
€197M
sum of rounds joined
Deals by year
distinct rounds / yearBrandon Capital — deals by year — interactive chart.
Data table
| Brandon Capital — deals by year | |
|---|---|
| 2022 | 3 |
| 2025 | 1 |
Top sectors
by dealsBrandon Capital — top sectors — interactive chart.
Data table
| Brandon Capital — top sectors | |
|---|---|
| Healthtech | 4 |
Stages
by dealsBrandon Capital — stages — interactive chart.
Data table
| Brandon Capital — stages | |
|---|---|
| Series A | 2 |
| Series B | 1 |
| Series C | 1 |
Countries
by dealsBrandon Capital — countries — interactive chart.
Data table
| Brandon Capital — countries | |
|---|---|
| UK | 3 |
| Germany | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| NRG Therapeutics | UK | 2 | €76M |
| Pheon Therapeutics | UK | 1 | €71M |
| CatalYm | Germany | 1 | €50M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Pheon Therapeutics | Series A | €71M | 2022-09 |
| NRG Therapeutics | Series B | €58M | 2025-09 |
| CatalYm | Series C | €50M | 2022-11 |
| NRG Therapeutics | Series A | €18M | 2022-11 |